1 | (2R)-2-Propyloctanoic acid | 1件: Arundic acid Arundic acid | 1件: D06296
D06296
| - | - | 1件: 2 2 |
2 | (6R)-4, 5, 6, 7 - tetrahydro-N6-propyl-2,6-benzothiazolidiamine dihydrochloride monohydrate | - | - | - | - | 1件: 2 2 |
3 | (R)-(-)-2-Propyloctaroic acid | - | - | - | - | 1件: 2 2 |
4 | 1.0 MIU IL-2 per day | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 2 2 |
5 | 1H-Pyrazol | 1件: Pyrazole Pyrazole | - | - | - | 5件: 2 2, 28, 46, 75, 154 |
6 | 2.0 MIU IL-2 per day | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 2 2 |
7 | 201600930 | - | - | - | - | 1件: 2 2 |
8 | 250 mg CK-2017357 | - | - | - | - | 2件: 2 2, 11 |
9 | 3-methyl-1-phenyl-4, 5-dihydro-1H-pyrazol-5-one. | 1件: Pyrazole Pyrazole | - | - | - | 1件: 2 2 |
10 | 3K3A-APC Protein | - | - | - | - | 1件: 2 2 |
11 | 4 cholesten-3-one, oxime | - | - | - | - | 1件: 2 2 |
12 | 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-thiazolyl]amino]phenyl]-benzamide, methane sulphonic acid salt. AB1010base | 1件: Methane Methane | - | - | - | 1件: 2 2 |
13 | 4-cholesten-3-one, oxime | - | - | - | - | 2件: 2 2, 3 |
14 | 40 mg GA | - | - | - | - | 2件: 2 2, 13 |
15 | 40 mg glatiramer acetate | 2件: Acetate Acetate, Glatiramer | 1件: D04318
D04318
| 20件: HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 2件: 2 2, 13 |
16 | 5% glucose water solution | 2件: Dextrose, unspecified form Dextrose, unspecified form, Water | 1件: D00001
D00001
| - | - | 1件: 2 2 |
17 | 500 mg CK-2017357 | - | - | - | - | 2件: 2 2, 11 |
18 | 6-ethynyl-1-(pentan-3-yl)-1H-imidazo[4,5-b]pyrazin-2(3H)-one | - | - | - | - | 1件: 2 2 |
19 | 9-CIS, 12-CIS-11,11-D2-LINOLEIC ACID ETHYL ESTER | 1件: Linoleic acid Linoleic acid | - | - | - | 2件: 2 2, 5 |
20 | [11C]CPPC Injection | - | - | - | - | 1件: 2 2 |
21 | [11C]MPC6827 | - | - | - | - | 1件: 2 2 |
22 | [18F] GE-180 | - | - | - | - | 1件: 2 2 |
23 | [18F]DPA-714 PET | - | - | - | - | 1件: 2 2 |
24 | [18F]PBR06 | - | - | - | - | 1件: 2 2 |
25 | AB 1003 | - | - | - | - | 1件: 2 2 |
26 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 |
27 | Abacavir | 1件: Abacavir Abacavir | 2件: D00891
D00891
,
D07057
| - | - | 4件: 2 2, 135, 265, 325 |
28 | ABBV-CLS-7262 | - | - | - | - | 1件: 2 2 |
29 | Acetate | 1件: Acetate Acetate | - | - | - | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
30 | Acetylcarnitine | 1件: Acetylcarnitine Acetylcarnitine | - | - | - | 2件: 2 2, 265 |
31 | ACIDO TAUROURSODESOSSICOLICO | - | - | - | - | 1件: 2 2 |
32 | Acthar | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 9件: 2 2, 13, 14, 46, 49, 50, 66, 84, 222 |
33 | Actos 15 mg | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 |
34 | Actos 30 mg | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 |
35 | Actos 45 mg | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 1件: 2 2 |
36 | AL001 | - | - | - | - | 2件: 2 2, 127 |
37 | Albumin | - | - | - | - | 3件: 2 2, 20, 51 |
38 | Albutein 5% | - | - | - | - | 1件: 2 2 |
39 | Albúmina humana | - | - | - | - | 1件: 2 2 |
40 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-P-thioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-P-thioadenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidine | - | - | - | - | 1件: 2 2 |
41 | All-P-ambo-2'-O-(2-methoxyethyl)-P-thioguanylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methylcytidylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)adenylyl-(3'-O->5'-O)-2'-O-(2-methoxyethyl)-5-methyluridylyl-(3'-O->5'-O)-2'-deoxy-P-thioguanylyl-(3'-O->5'-O)-P-thiothymidylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy-Pthioadenylyl-(3'-O->5'-O)-2'-deoxy-5-methyl-P-thiocytidylyl-(3'-O->5'-O)-2'-deoxy- | - | - | - | - | 1件: 2 2 |
42 | AlloRx | - | - | - | - | 8件: 2 2, 6, 13, 46, 51, 85, 90, 226 |
43 | ALPHA-LIPOIC ACID | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 2件: 2 2, 13 |
44 | ALXN1210 | - | - | - | - | 7件: 2 2, 11, 13, 50, 62, 66, 109 |
45 | ALZT-OP1a (cromolyn) | 1件: Cromoglicic acid Cromoglicic acid | 2件: D00526
D00526
,
D07753
| - | - | 1件: 2 2 |
46 | Amivita | - | - | - | - | 1件: 2 2 |
47 | AMSC | - | - | - | - | 1件: 2 2 |
48 | AMX0035 | - | - | - | - | 1件: 2 2 |
49 | Anakinra | 1件: Anakinra Anakinra | 1件: D02934
D02934
| 2件: IL1R1 IL1R1, IL1R2 💬 | 15件: Amoebiasis Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 56, 84, 86, 97, 106, 107, 299 |
50 | ANX005 | - | - | - | - | 3件: 2 2, 8, 61 |
51 | AP | - | - | - | - | 4件: 2 2, 6, 13, 299 |
52 | AP-101 | - | - | - | - | 1件: 2 2 |
53 | APL-2 | - | - | - | - | 5件: 2 2, 61, 62, 66, 222 |
54 | APO-P001 | - | - | - | - | 1件: 2 2 |
55 | ARIMOCLOMOL | 1件: Arimoclomol Arimoclomol | 1件: D11374
D11374
| - | - | 3件: 2 2, 15, 19 |
56 | Arundic Acid | 1件: Arundic acid Arundic acid | 1件: D06296
D06296
| - | - | 1件: 2 2 |
57 | AstroRx | - | - | - | - | 1件: 2 2 |
58 | AT-1501 | - | - | - | - | 2件: 2 2, 66 |
59 | Atropine | 1件: Atropine Atropine | 5件: D00113
D00113
,
D01077
,
D02069
,
D03011
,
D03814
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
60 | Autologous Adipose-derived Mesenchymal Stromal Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 1件: 2 2 |
61 | Autologous adult bone marrow mononuclear cells (BM-MNC) unexpanded | - | - | - | - | 1件: 2 2 |
62 | Autologous adult bone marrow mononuclear cells unexpanded | - | - | - | - | 1件: 2 2 |
63 | Autologous bone marrow mononucleated cells | - | - | - | - | 1件: 2 2 |
64 | Autologous bone marrow-derived stem cells | - | - | - | - | 1件: 2 2 |
65 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 |
66 | Autologous Mesenchymal stem cells (MSCs) | - | - | - | - | 1件: 2 2 |
67 | Autologous MSC-NTF cells | - | - | - | - | 1件: 2 2 |
68 | Autologous T-regulatory lymphocytes | - | - | - | - | 1件: 2 2 |
69 | AVP-923 | - | - | - | - | 3件: 2 2, 6, 13 |
70 | Azilect | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
71 | AZILECT® 1 mg Tabletten | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 2 2 |
72 | Baclofen | 1件: Baclofen Baclofen | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 7件: 2 2, 10, 13, 18, 65, 149, 206 |
73 | Barium | 1件: Barium Barium | - | - | - | 3件: 2 2, 19, 98 |
74 | Basiliximab | 1件: Basiliximab Basiliximab | 1件: D03058
D03058
| 1件: IL2RA IL2RA 💬 | 11件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 2 2, 50, 97, 222, 228 |
75 | Behavioral: BCI-FIT active querying | - | - | - | - | 3件: 2 2, 6, 17 |
76 | Behavioral: BCI-FIT adaptive signal modeling | - | - | - | - | 3件: 2 2, 6, 17 |
77 | Behavioral: BCI-FIT language modeling | - | - | - | - | 3件: 2 2, 6, 17 |
78 | Behavioral: BCI-FIT multi-modal access | - | - | - | - | 3件: 2 2, 6, 17 |
79 | Behavioral: SIT Scoring | - | - | - | - | 1件: 2 2 |
80 | Behavioral: Speech Intelligibility Test (SIT) | - | - | - | - | 1件: 2 2 |
81 | Beta Hydroxybutyrate | - | - | - | - | 1件: 2 2 |
82 | Betamethasone | 1件: Betamethasone Betamethasone | 7件: D00244
D00244
,
D00972
,
D01357
,
D01402
,
D01637
,
D02032
,
D02286
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 7件: 2 2, 28, 46, 83, 90, 96, 235 |
83 | Betamethasone sodium phosphate/betamethasone acetate (Celestone® Soluspan®), 30 mg IM once a day for four days | 3件: Acetate Acetate, Betamethasone, Phosphate ion | 7件: D00244
D00244
,
D00972
,
D01357
,
D01402
,
D01637
,
D02032
,
D02286
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 |
84 | BHV-0223 | - | - | - | - | 1件: 2 2 |
85 | BIIB050 / KNS-760704 | - | - | - | - | 1件: 2 2 |
86 | BIIB050/KNS-760704 | - | - | - | - | 1件: 2 2 |
87 | BIIB067 | - | - | - | - | 1件: 2 2 |
88 | BIIB067 (ISIS666853) | - | - | - | - | 1件: 2 2 |
89 | BIIB067 (Tofersen) | 1件: Tofersen Tofersen | 1件: D11811
D11811
| 1件: SOD1 SOD1 💬 | 8件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬 | 1件: 2 2 |
90 | BIIB078 | - | - | - | - | 1件: 2 2 |
91 | BIIB100 | - | - | - | - | 1件: 2 2 |
92 | BIIB105 | - | - | - | - | 1件: 2 2 |
93 | Biologic: IC14 (monoclonal antibody against human CD14) | - | - | - | - | 1件: 2 2 |
94 | BIOTIN | 1件: Biotin Biotin | 1件: D00029
D00029
| - | - | 5件: 2 2, 8, 10, 13, 20 |
95 | Blood sample and environmental survey | - | - | - | - | 1件: 2 2 |
96 | BLZ945 | - | - | - | - | 1件: 2 2 |
97 | Bosutinib | 1件: Bosutinib Bosutinib | 1件: D03252
D03252
| 2件: ABL1 ABL1, SRC 💬 | 49件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 2件: 2 2, 67 |
98 | Botox | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 6件: 2 2, 6, 13, 51, 149, 226 |
99 | BOTOX 100 UNITES ALLERGAN (PR1) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 2 2 |
100 | Botox injection | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 2 2 |
101 | BOTULINUM TOXIN TYPE A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 10件: 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
102 | Botulinum toxin type B | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 51 |
103 | Botulinum toxin type B (Myobloc) | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 2 2, 6 |
104 | BRX-345 | - | - | - | - | 2件: 2 2, 15 |
105 | Butylphthalide | 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 18, 22 |
106 | Caffeine | 1件: Caffeine Caffeine | 2件: D00528
D00528
,
D01453
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 2 2, 6, 13, 21, 46, 78, 96, 97, 265 |
107 | Calogen | - | - | - | - | 1件: 2 2 |
108 | Cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 9件: 2 2, 6, 13, 19, 46, 90, 96, 97, 271 |
109 | Cannabis Sativa extract Oromucosal spray | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 2 2 |
110 | Cannabis, Medical | 1件: Medical Cannabis Medical Cannabis | - | - | - | 5件: 2 2, 6, 13, 96, 97 |
111 | Capsaicin | 1件: Capsaicin Capsaicin | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 5件: 2 2, 6, 19, 86, 226 |
112 | Capsaicin Challenge | 1件: Capsaicin Capsaicin | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 2 2 |
113 | Carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 9件: 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
114 | Carbidopa-levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 3件: 2 2, 4, 6 |
115 | CARBOLITHIUM | - | - | - | - | 1件: 2 2 |
116 | CARBOLITHIUM*100CPS 150MG | - | - | - | - | 1件: 2 2 |
117 | Carbonate | 1件: Carbonate ion Carbonate ion | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
118 | Carbonate de lithium | 1件: Carbonate ion Carbonate ion | - | - | - | 1件: 2 2 |
119 | CBD | - | - | - | - | 12件: 2 2, 6, 8, 13, 36, 46, 140, 144, 145, 156, 158, 206 |
120 | CC100 | - | - | - | - | 1件: 2 2 |
121 | Ceftriaxone | 1件: Ceftriaxone Ceftriaxone | 2件: D00924
D00924
,
D07659
| - | - | 3件: 2 2, 6, 97 |
122 | Celecoxib | 1件: Celecoxib Celecoxib | 1件: D00567
D00567
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 10件: 2 2, 3, 34, 46, 70, 89, 107, 161, 171, 271 |
123 | Cell-based therapeutics | - | - | - | - | 1件: 2 2 |
124 | Cell-based therapy | - | - | - | - | 1件: 2 2 |
125 | Cell-based therapy of autologous adipose derived regenerative cells transplanted intraspinally and intrathecally in ALS patients | - | - | - | - | 1件: 2 2 |
126 | CENSAVUDINE | 1件: Censavudine Censavudine | 1件: D10550
D10550
| - | - | 2件: 2 2, 127 |
127 | Cimetidine | 1件: Cimetidine Cimetidine | 2件: D00295
D00295
,
D03503
| 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 2件: 2 2, 254 |
128 | Cimetidine plus Dexpramipexole | 2件: Cimetidine Cimetidine, Dexpramipexole | 3件: D00295
D00295
,
D03503
,
D09886
| 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, HRH2 💬 | 12件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
129 | Ciprofloxacin | 1件: Ciprofloxacin Ciprofloxacin | 2件: D00186
D00186
,
D02216
| - | - | 5件: 2 2, 60, 96, 97, 299 |
130 | Cistanche Total Glycosides | - | - | - | - | 1件: 2 2 |
131 | CK-2017357 | - | - | - | - | 1件: 2 2 |
132 | CK-2017357 (Part A) | - | - | - | - | 1件: 2 2 |
133 | CK-2017357 (Part B) | - | - | - | - | 1件: 2 2 |
134 | CK-2127107 | 1件: Reldesemtiv Reldesemtiv | 1件: D11363
D11363
| 1件: TNNC2 TNNC2 💬 | 1件: Calcium signaling pathway Calcium signaling pathway 💬 | 1件: 2 2 |
135 | CK2017357 | - | - | - | - | 1件: 2 2 |
136 | Clenbuterol | 1件: Clenbuterol Clenbuterol | 1件: D07713
D07713
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 1 1, 2, 6, 256 |
137 | CLS | - | - | - | - | 3件: 2 2, 46, 71 |
138 | CNM-Au8 | - | - | - | - | 2件: 2 2, 13 |
139 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: D01065
D01065
| - | - | 12件: 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215 |
140 | COLCHICINA | 1件: Colchicine Colchicine | 1件: D00570
D00570
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 |
141 | COLCHICINA LIRCA - 1 MG COMPRESSE 60 COMPRESSE | 1件: Colchicine Colchicine | 1件: D00570
D00570
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 |
142 | Colchicine | 1件: Colchicine Colchicine | 1件: D00570
D00570
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 7件: 2 2, 42, 46, 56, 93, 210, 266 |
143 | Colchicine 1 MG Oral Tablet | 1件: Colchicine Colchicine | 1件: D00570
D00570
| 9件: TUBB TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 | 10件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | 1件: 2 2 |
144 | Combination Product: Active treatment with dual therapy | - | - | - | - | 1件: 2 2 |
145 | Control group | - | - | - | - | 5件: 2 2, 34, 46, 70, 235 |
146 | Copegus | 1件: Ribavirin Ribavirin | 1件: D00423
D00423
| - | - | 1件: 2 2 |
147 | Copper | 1件: Copper Copper | - | - | - | 4件: 2 2, 169, 170, 171 |
148 | Cord blood therapy | 1件: Umbilical Cord Blood Hematopoietic Stem Cells Umbilical Cord Blood Hematopoietic Stem Cells | - | - | - | 2件: 2 2, 6 |
149 | Corticotropin | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 9件: 2 2, 13, 46, 75, 78, 81, 84, 205, 222 |
150 | Creatine | 1件: Creatine Creatine | - | - | - | 16件: 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
151 | Creatine Monohydrate | 1件: Creatine Creatine | - | - | - | 4件: 2 2, 8, 113, 156 |
152 | Creatinine | 1件: Creatinine Creatinine | 1件: D03600
D03600
| - | - | 4件: 2 2, 46, 60, 70 |
153 | Cromolyn | 1件: Cromoglicic acid Cromoglicic acid | 2件: D00526
D00526
,
D07753
| - | - | 3件: 2 2, 85, 98 |
154 | Cu(II)ATSM | - | - | - | - | 2件: 2 2, 6 |
155 | Curcumin | 1件: Curcumin Curcumin | - | - | - | 11件: 2 2, 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 |
156 | Células madre mesenquimales de tejido adiposo autólogo | - | - | - | - | 1件: 2 2 |
157 | Células Mesenquimales de tejido adiposo | - | - | - | - | 1件: 2 2 |
158 | Células troncales hematopoyéticas autólogas adultas extraidas de médula ósea | - | - | - | - | 1件: 2 2 |
159 | Daraprim | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 2件: 2 2, 4 |
160 | Darunavir | 1件: Darunavir Darunavir | 1件: D03656
D03656
| - | - | 1件: 2 2 |
161 | DaTSCAN | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 4件: 2 2, 5, 6, 17 |
162 | DEFERIPRONE | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
163 | Deferiprone DR | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 2件: 2 2, 6 |
164 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 |
165 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
166 | Dexpramipexole | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
167 | Dexpramipexole (dose 1) | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
168 | Dexpramipexole (dose 2) | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
169 | Dexpramipexole Dichydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
170 | Dexpramipexole Dihydrochloride | 1件: Dexpramipexole Dexpramipexole | 1件: D09886
D09886
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
171 | Dextran | 1件: Dextran Dextran | 1件: D00060
D00060
| - | - | 5件: 2 2, 62, 79, 96, 97 |
172 | Dextran Sodium Sulfur Salt 5, Mw 5 kDa. a type of Low Molecular Weight Dextran Sulfate (LMW-DS) | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 2 2 |
173 | DEXTRAN SULFATE SODIUM | 2件: Dextran Dextran, Sulfate ion | 1件: D00060
D00060
| - | - | 1件: 2 2 |
174 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
175 | Dextromethorphan HBr and quinidine sulfate | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
176 | Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
177 | Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg | 3件: Dextromethorphan Dextromethorphan, Quinidine, Sulfate ion | 7件: D00642
D00642
,
D00643
,
D00848
,
D02272
,
D03742
,
D03744
,
D08458
| 11件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 | 22件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway 💬 | 2件: 2 2, 13 |
178 | Digital recording of speech and swallow sounds using the Beiwe Digital Health App on a personal smartphone | - | - | - | - | 1件: 2 2 |
179 | DNL343 | - | - | - | - | 1件: 2 2 |
180 | DNL747 | - | - | - | - | 1件: 2 2 |
181 | Dolutegravir | 1件: Dolutegravir Dolutegravir | 1件: D10066
D10066
| - | - | 2件: 2 2, 265 |
182 | DPA | - | - | - | - | 5件: 2 2, 6, 13, 85, 127 |
183 | Dronabinol | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 5件: 2 2, 13, 46, 271, 298 |
184 | Drug: F 18 T807 | - | - | - | - | 1件: 2 2 |
185 | Dutasterida | 1件: Dutasteride Dutasteride | 1件: D03820
D03820
| 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 2 2 |
186 | Dutasteride | 1件: Dutasteride Dutasteride | 1件: D03820
D03820
| 2件: SRD5A1 SRD5A1, SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 2件: 1 1, 2 |
187 | E0302 (mecobalamin) | 1件: Mecobalamin Mecobalamin | 1件: D03246
D03246
| - | - | 1件: 2 2 |
188 | EBIXA | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 13 |
189 | EDARAVONE | 1件: Edaravone Edaravone | 1件: D01552
D01552
| - | - | 2件: 2 2, 22 |
190 | EH301 (Nicotinamide Riboside/Pterostilbene) | 2件: Nicotinamide Nicotinamide, Nicotinamide riboside | 1件: D00036
D00036
| - | - | 1件: 2 2 |
191 | Electrical Impedance Myography | - | - | - | - | 1件: 2 2 |
192 | Endocannabinoid palmitoylethanolamide (PEA) | 1件: Palmidrol Palmidrol | 1件: D08328
D08328
| - | - | 1件: 2 2 |
193 | Engensis | - | - | - | - | 1件: 2 2 |
194 | Enoxacin | 1件: Enoxacin Enoxacin | 2件: D00310
D00310
,
D05461
| - | - | 1件: 2 2 |
195 | EPERISONE | 1件: Eperisone Eperisone | 1件: D07898
D07898
| - | - | 1件: 2 2 |
196 | EPI-589 | 1件: EPI-589 EPI-589 | - | - | - | 2件: 2 2, 6 |
197 | EPREX IV SC 1FL 1ML 40000 UI | - | - | - | - | 1件: 2 2 |
198 | EPREX*1SIR 40000UI/ML 1ML | - | - | - | - | 2件: 2 2, 18 |
199 | Eril® | - | - | - | - | 1件: 2 2 |
200 | Erythropoetin (EPO) | - | - | - | - | 1件: 2 2 |
201 | ERYTHROPOIETIN | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 9件: 2 2, 6, 13, 18, 22, 47, 70, 95, 96 |
202 | Escitalopram | 1件: Escitalopram Escitalopram | 3件: D02567
D02567
,
D07704
,
D07913
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 13 |
203 | ESKETAMINE | 1件: Esketamine Esketamine | 1件: D07283
D07283
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 4, 70 |
204 | Ezogabine | 1件: Ezogabine Ezogabine | 1件: D09569
D09569
| 5件: KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | 6件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | 2件: 2 2, 144 |
205 | FAB122 | - | - | - | - | 1件: 2 2 |
206 | FamC-1 | - | - | - | - | 1件: 2 2 |
207 | Fasudil | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 5, 7, 51 |
208 | Fasudil (WP-0512) | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
209 | FASUDIL HYDROCHLORIDE | 1件: Fasudil Fasudil | 1件: D07941
D07941
| 2件: ROCK1 ROCK1, ROCK2 💬 | 23件: Axon guidance Axon guidance, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
210 | Febuxostat | 1件: Febuxostat Febuxostat | 1件: D01206
D01206
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 3件: 2 2, 6, 13 |
211 | Fecal microbiota transplantation | - | - | - | - | 5件: 2 2, 66, 94, 96, 97 |
212 | Fenilbutirato | - | - | - | - | 1件: 2 2 |
213 | Fig | 1件: Fig Fig | - | - | - | 1件: 2 2 |
214 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 28件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
215 | Fixed dose combination Ciprofloxacin/Celecoxib | 2件: Celecoxib Celecoxib, Ciprofloxacin | 3件: D00186
D00186
,
D00567
,
D02216
| 1件: PTGS2 PTGS2 💬 | 22件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 1件: 2 2 |
216 | FLX-787-ODT | - | - | - | - | 1件: 2 2 |
217 | FLX-787-ODT (orally disintigrating tablet) | - | - | - | - | 1件: 2 2 |
218 | Fycompa | 1件: Perampanel Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 144 |
219 | G-CSF | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 16件: 2 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 |
220 | G04CB02 | - | - | - | - | 1件: 2 2 |
221 | GDC-0134 | - | - | - | - | 1件: 2 2 |
222 | Gilenya | - | - | - | - | 3件: 2 2, 13, 14 |
223 | Glatiramer | 1件: Glatiramer Glatiramer | 1件: D04318
D04318
| 20件: HLA-A HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 | 32件: Allograft rejection Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 💬 | 4件: 2 2, 13, 96, 156 |
224 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 15件: 2 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 |
225 | GM604 | - | - | - | - | 1件: 2 2 |
226 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
227 | Gold Nanocrystals | - | - | - | - | 3件: 2 2, 6, 13 |
228 | Granulocyte - colony stimulating factor (G-CSF) | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 2 2 |
229 | Granulocyte Colony Stimulating Factor | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 6件: 2 2, 28, 36, 57, 65, 85 |
230 | Growth hormone | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 13件: 2 2, 13, 19, 46, 78, 96, 107, 187, 191, 193, 195, 265, 299 |
231 | Growth Hormone (Somatropin) | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 2件: 2 2, 78 |
232 | GSK1223249 | - | - | - | - | 2件: 2 2, 13 |
233 | GUANA2015 | - | - | - | - | 1件: 2 2 |
234 | GUANABENZ | 1件: Guanabenz Guanabenz | 1件: D04375
D04375
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 13 |
235 | GUANABENZ ACETATO | 1件: Guanabenz Guanabenz | 1件: D04375
D04375
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
236 | HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 7件: 2 2, 4, 6, 13, 46, 49, 113 |
237 | High-caloric fatty diet | - | - | - | - | 1件: 2 2 |
238 | HK-001 | - | - | - | - | 1件: 2 2 |
239 | Human albumin | 1件: Albumin human Albumin human | 2件: D02792
D02792
,
D05424
| - | - | 2件: 2 2, 96 |
240 | HUMAN ALBUMIN SOLUTION | 1件: Albumin human Albumin human | 2件: D02792
D02792
,
D05424
| - | - | 1件: 2 2 |
241 | Human autologous mesenchymal stem cells | - | - | - | - | 2件: 2 2, 13 |
242 | Human Neural Stem Cells | - | - | - | - | 2件: 2 2, 13 |
243 | Huolingshengji Granules | - | - | - | - | 1件: 2 2 |
244 | HYNR-CS inj | - | - | - | - | 1件: 2 2 |
245 | HYNRCS-Allo inj | - | - | - | - | 1件: 2 2 |
246 | Hyperpolarized [1-13C]pyruvate | - | - | - | - | 2件: 2 2, 67 |
247 | I-123 | 1件: Iodide I-123 Iodide I-123 | - | - | - | 2件: 2 2, 6 |
248 | I-123] ADAM | 1件: Iodide I-123 Iodide I-123 | - | - | - | 1件: 2 2 |
249 | IBUDILAST | 1件: Ibudilast Ibudilast | 1件: D01385
D01385
| 8件: CYSLTR1 CYSLTR1, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PTGIR 💬 | 16件: Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 13 |
250 | IC14 | - | - | - | - | 1件: 2 2 |
251 | Icerguastat | - | - | - | - | 1件: 2 2 |
252 | IFB-088 | - | - | - | - | 1件: 2 2 |
253 | IL-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 7件: 2 2, 46, 49, 53, 56, 96, 107 |
254 | ILB | - | - | - | - | 1件: 2 2 |
255 | ILB: 100mg/ml solution for injection and infusion | - | - | - | - | 1件: 2 2 |
256 | IMMUNOGLOBULIN G | - | - | - | - | 8件: 2 2, 11, 13, 14, 49, 50, 63, 65 |
257 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy | - | - | - | - | 1件: 2 2 |
258 | Immunoglobulin G1, anti (protein Nogo A) (human Mus musculus monoclonal heavy chain), disulfide with human Mus musculus monoclonal light chain, dimer | - | - | - | - | 1件: 2 2 |
259 | Incobotulinum Toxin A | - | - | - | - | 3件: 2 2, 6, 13 |
260 | Injection of salivary glands | - | - | - | - | 1件: 2 2 |
261 | Inosine | 1件: Inosine Inosine | 1件: D00054
D00054
| - | - | 5件: 2 2, 6, 13, 17, 122 |
262 | Insulin like growth factor, type 1 | - | - | - | - | 1件: 2 2 |
263 | INTERLEUKIN-2 | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 8件: 2 2, 35, 49, 55, 65, 96, 97, 162 |
264 | Intra venous injection of stem cell | - | - | - | - | 1件: 2 2 |
265 | Intrathecal autologous stem cell | - | - | - | - | 1件: 2 2 |
266 | Intrathecal injection | - | - | - | - | 1件: 2 2 |
267 | Intravenous administration of 1 million of MSC | - | - | - | - | 1件: 2 2 |
268 | Intravenous administration of 2 million of MSC | - | - | - | - | 1件: 2 2 |
269 | Intravenous administration of 4 million of MSC | - | - | - | - | 1件: 2 2 |
270 | Intraventricular injection | - | - | - | - | 1件: 2 2 |
271 | Ioflupane 123I | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 2 2 |
272 | ION363 | - | - | - | - | 1件: 2 2 |
273 | Iowa Oral Performance Instrument | - | - | - | - | 1件: 2 2 |
274 | Iowa Oral Pressure Instrument | - | - | - | - | 1件: 2 2 |
275 | IPL344 | - | - | - | - | 1件: 2 2 |
276 | ISIS 333611 | - | - | - | - | 1件: 2 2 |
277 | Isocaloric Diet | - | - | - | - | 2件: 2 2, 83 |
278 | Jevity 1.0 | - | - | - | - | 1件: 2 2 |
279 | Jevity 1.5 | - | - | - | - | 1件: 2 2 |
280 | Ketanest | - | - | - | - | 3件: 2 2, 4, 70 |
281 | Ketanest-S | - | - | - | - | 3件: 2 2, 4, 70 |
282 | KetoCal | - | - | - | - | 1件: 2 2 |
283 | KNS-760704 | - | - | - | - | 1件: 2 2 |
284 | L-Serine | 1件: Serine Serine | 1件: D00016
D00016
| - | - | 1件: 2 2 |
285 | Lacosamide | 1件: Lacosamide Lacosamide | 1件: D07299
D07299
| 2件: SCN3A SCN3A, SCN9A 💬 | 1件: Taste transduction Taste transduction 💬 | 3件: 2 2, 46, 149 |
286 | Lactose | 1件: Lactose Lactose | 2件: D00046
D00046
,
D03226
| - | - | 6件: 2 2, 6, 13, 97, 228, 310 |
287 | LAM-002A | - | - | - | - | 1件: 2 2 |
288 | Lamivudine | 1件: Lamivudine Lamivudine | 1件: D00353
D00353
| - | - | 7件: 2 2, 26, 42, 46, 135, 265, 325 |
289 | Lenograstim | 1件: Lenograstim Lenograstim | 1件: D03247
D03247
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 7件: 2 2, 13, 16, 18, 19, 57, 65 |
290 | Lenzumestrocel | - | - | - | - | 1件: 2 2 |
291 | Leuprolide | 1件: Leuprolide Leuprolide | 1件: D00989
D00989
| 1件: GNRHR GNRHR 💬 | 2件: GnRH signaling pathway GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬 | 5件: 1 1, 2, 3, 51, 76 |
292 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 |
293 | Levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
294 | LEVOSIMENDAN | 1件: Levosimendan Levosimendan | 1件: D04720
D04720
| 2件: PDE3A PDE3A, PDE3B 💬 | 11件: Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
295 | Linoleic acid | 1件: Linoleic acid Linoleic acid | - | - | - | 4件: 2 2, 5, 13, 299 |
296 | LIORESAL*50CPR 10MG | 1件: Baclofen Baclofen | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
297 | Lipoic acid | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 5件: 2 2, 5, 13, 14, 20 |
298 | Lipoic acid group | 1件: Lipoic acid Lipoic acid | 2件: D00048
D00048
,
D00086
| - | - | 1件: 2 2 |
299 | Liposomed polyphenols resveratrol and curcumin | 2件: Curcumin Curcumin, Resveratrol | - | - | - | 1件: 2 2 |
300 | Lithium | 1件: Lithium citrate Lithium citrate | 1件: D04749
D04749
| - | - | 5件: 2 2, 5, 6, 7, 8 |
301 | Lithium Apogepha | 1件: Lithium citrate Lithium citrate | 1件: D04749
D04749
| - | - | 1件: 2 2 |
302 | LITHIUM CARBONATE | 2件: Carbonate ion Carbonate ion, Lithium carbonate | 1件: D00801
D00801
| - | - | 6件: 2 2, 13, 17, 18, 19, 127 |
303 | LITHIUM CITRATE | 1件: Lithium citrate Lithium citrate | 1件: D04749
D04749
| - | - | 1件: 2 2 |
304 | Lithiumcarbonaat | - | - | - | - | 1件: 2 2 |
305 | Lithiumcarbonaat 400 PCH tabletten | - | - | - | - | 1件: 2 2 |
306 | LITIO CARBONATO | - | - | - | - | 2件: 2 2, 17 |
307 | Lunasin | 1件: Lunasine Lunasine | - | - | - | 1件: 2 2 |
308 | Lunasin Regimen | 1件: Lunasine Lunasine | - | - | - | 1件: 2 2 |
309 | MANNITOLO 18% | - | - | - | - | 1件: 2 2 |
310 | MANNITOLO 18% LDB | - | - | - | - | 1件: 2 2 |
311 | MASITINIB | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
312 | Masitinib (3.0) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
313 | Masitinib (4.5) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
314 | Masitinib (6.0) | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
315 | Masitinib 100 mg Tablets | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
316 | Masitinib 100mg | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 5 |
317 | Masitinib 200 mg Tablets | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 1件: 2 2 |
318 | Masitinib 200mg | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 5 |
319 | Masitinib mesilate | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 2件: 2 2, 13 |
320 | MASITINIB MESYLATE | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
321 | MCI-186 | - | - | - | - | 1件: 2 2 |
322 | MCI-186 in open label phase | - | - | - | - | 1件: 2 2 |
323 | MD1003 | - | - | - | - | 5件: 2 2, 10, 13, 14, 20 |
324 | Mecobalamin | 1件: Mecobalamin Mecobalamin | 1件: D03246
D03246
| - | - | 2件: 2 2, 70 |
325 | MediCabilis CBD Oil | - | - | - | - | 1件: 2 2 |
326 | Medicine | - | - | - | - | 1件: 2 2 |
327 | Memantine | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 7件: 2 2, 6, 8, 13, 49, 127, 205 |
328 | Memantine (Ebixa) | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 |
329 | MEMANTINE HYDROCHLORIDE | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 127 |
330 | Memantine Hydrochloride Oral Solution | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 2 2 |
331 | Mesenchymal stem cell | - | - | - | - | 1件: 2 2 |
332 | Mesenchymal stem cells | - | - | - | - | 11件: 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
333 | Mesenchymal stem cells (MSC) | - | - | - | - | 3件: 2 2, 13, 96 |
334 | Mesenchymal stem cells isolated from Wharton's jelly | - | - | - | - | 1件: 2 2 |
335 | Mesenchymal Stromal Cells | 1件: Human Umbilical Cord Mesenchymal Stem Cells Human Umbilical Cord Mesenchymal Stem Cells | - | - | - | 10件: 2 2, 36, 49, 51, 60, 96, 97, 107, 274, 284 |
336 | Metformin | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
337 | Methane | 1件: Methane Methane | - | - | - | 1件: 2 2 |
338 | Methylcobalamin | 1件: Mecobalamin Mecobalamin | 1件: D03246
D03246
| - | - | 1件: 2 2 |
339 | Methylphenylpyrazolone | 1件: Edaravone Edaravone | 1件: D01552
D01552
| - | - | 1件: 2 2 |
340 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
341 | Mexiletine | 1件: Mexiletine Mexiletine | 2件: D00639
D00639
,
D08215
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 5件: 1 1, 2, 10, 113, 114 |
342 | Micro Mouth Pressure Meter | - | - | - | - | 1件: 2 2 |
343 | Midazolam | 1件: Midazolam Midazolam | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
344 | Minocycline | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
345 | MN-166 | - | - | - | - | 1件: 2 2 |
346 | MNC (Mononuclear cells) | - | - | - | - | 1件: 2 2 |
347 | Modal | - | - | - | - | 5件: 2 2, 6, 17, 46, 70 |
348 | MONITOR | 1件: Methamidophos Methamidophos | - | - | - | 20件: 2 2, 11, 13, 19, 28, 46, 49, 58, 65, 70, 81, 85, 86, 98, 113, 118, 129, 298, 299, 300 |
349 | Monthly autologous Treg cells infusions + 3 times per week Interleukin-2 injections | 1件: Human interleukin-2 Human interleukin-2 | - | - | - | 1件: 2 2 |
350 | Moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 9件: 2 2, 6, 46, 49, 85, 86, 113, 240, 299 |
351 | MSC-NTF cells transplantation (IM) | - | - | - | - | 1件: 2 2 |
352 | MSC-NTF cells transplantation (IT) | - | - | - | - | 1件: 2 2 |
353 | MSC_NTF cells transplantation by multiple intramuscular injections at 24 separate sites, in addition to a single intrathechal injection into the CSF | - | - | - | - | 1件: 2 2 |
354 | MT-1186 | - | - | - | - | 1件: 2 2 |
355 | Multiple Dose | - | - | - | - | 1件: 2 2 |
356 | Mycophenolate | 1件: Mycophenolic acid Mycophenolic acid | 1件: D05096
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 36件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 |
357 | Mycophenolate mofetil | 2件: Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | 4件: D00752
D00752
,
D05094
,
D05095
,
D05096
| 2件: IMPDH1 IMPDH1, IMPDH2 💬 | 3件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | 34件: 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 49, 51, 53, 60, 61, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 |
358 | MYELOSTIM 34*1FL 263MCG+1SIR | - | - | - | - | 1件: 2 2 |
359 | Myonal | - | - | - | - | 1件: 2 2 |
360 | MYONAL*30CPR RIV 100MG | - | - | - | - | 1件: 2 2 |
361 | Nd | - | - | - | - | 6件: 2 2, 6, 13, 46, 51, 97 |
362 | Nicotinamide | 1件: Nicotinamide Nicotinamide | 1件: D00036
D00036
| - | - | 8件: 2 2, 6, 18, 49, 65, 107, 162, 191 |
363 | Nicotinamide riboside | 2件: Nicotinamide Nicotinamide, Nicotinamide riboside | 1件: D00036
D00036
| - | - | 4件: 2 2, 6, 18, 191 |
364 | Norantipyrine | - | - | - | - | 1件: 2 2 |
365 | Norphenazone | 1件: Edaravone Edaravone | 1件: D01552
D01552
| - | - | 1件: 2 2 |
366 | NP001 | - | - | - | - | 1件: 2 2 |
367 | NS | - | - | - | - | 1件: 2 2 |
368 | Nuedexta | - | - | - | - | 1件: 2 2 |
369 | NurOwn® (MSC-NTF cells) | - | - | - | - | 1件: 2 2 |
370 | ODM-109 | - | - | - | - | 1件: 2 2 |
371 | ODM-109 capsule 1 mg | - | - | - | - | 1件: 2 2 |
372 | OLANZAPINE | 1件: Olanzapine Olanzapine | 2件: D00454
D00454
,
D06623
| 11件: ADRA1A ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 2 2, 8 |
373 | Olesoxime | - | - | - | - | 2件: 2 2, 3 |
374 | ONO-2506 | - | - | - | - | 1件: 2 2 |
375 | ONO-2506PO | - | - | - | - | 2件: 2 2, 6 |
376 | Oral LEVOSIMENDAN | 1件: Levosimendan Levosimendan | 1件: D04720
D04720
| 2件: PDE3A PDE3A, PDE3B 💬 | 11件: Apelin signaling pathway Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
377 | Oral nutritional supplementation | - | - | - | - | 1件: 2 2 |
378 | Other: | - | - | - | - | 2件: 2 2, 65 |
379 | Other: Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised | - | - | - | - | 1件: 2 2 |
380 | Other: Bone Marrow aspiration | - | - | - | - | 1件: 2 2 |
381 | Other: Communicative Effectiveness Survey | - | - | - | - | 1件: 2 2 |
382 | Other: Control group | - | - | - | - | 1件: 2 2 |
383 | Other: Eating Assessment Tool 10 | - | - | - | - | 1件: 2 2 |
384 | Other: Eating Assessment Tool-10 | - | - | - | - | 1件: 2 2 |
385 | Other: Functional Oral Intake Scale | - | - | - | - | 1件: 2 2 |
386 | Other: Historical control | - | - | - | - | 1件: 2 2 |
387 | Other: Other: Symptomatic treatment of ALS | - | - | - | - | 1件: 2 2 |
388 | Other: Saline | - | - | - | - | 8件: 2 2, 6, 46, 97, 98, 256, 274, 301 |
389 | Other: Swallowing Quality of Life Questionnaire | - | - | - | - | 1件: 2 2 |
390 | Other: Swallowing Related Quality of Life Questionnaire | - | - | - | - | 1件: 2 2 |
391 | Other: The Center for Neurologic Studies Bulbar Function Scale | - | - | - | - | 1件: 2 2 |
392 | Other: The Center for Neurologic Study Bulbar Function Scale | - | - | - | - | 1件: 2 2 |
393 | Oxepa | - | - | - | - | 1件: 2 2 |
394 | Ozanezumab | 1件: Ozanezumab Ozanezumab | 1件: D10331
D10331
| 1件: RTN4 RTN4 💬 | 1件: Alzheimer disease Alzheimer disease 💬 | 1件: 2 2 |
395 | Palmitoylethanolamide | 1件: Palmidrol Palmidrol | 1件: D08328
D08328
| - | - | 1件: 2 2 |
396 | PARACETAMOLO | - | - | - | - | 8件: 2 2, 11, 14, 28, 53, 61, 63, 300 |
397 | PBMC autotransplantation | - | - | - | - | 1件: 2 2 |
398 | Pegcetacoplam | - | - | - | - | 1件: 2 2 |
399 | PEGCETACOPLAN | 1件: Pegcetacoplan Pegcetacoplan | 1件: D11613
D11613
| 1件: C3 C3 💬 | 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 3件: 2 2, 62, 222 |
400 | Pegcetacoplan (APL-2) | 1件: Pegcetacoplan Pegcetacoplan | 1件: D11613
D11613
| 1件: C3 C3 💬 | 17件: Alcoholic liver disease Alcoholic liver disease, Chagas disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Phagosome, Shigellosis, Staphylococcus aureus infection, Systemic lupus erythematosus, Tuberculosis, Viral carcinogenesis 💬 | 2件: 2 2, 62 |
401 | Perampanel | 1件: Perampanel Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 6, 144 |
402 | PERFALGAN | - | - | - | - | 1件: 2 2 |
403 | PHENYLBUTYRATE | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 12件: 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
404 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 33件: 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
405 | Pimozide | 1件: Pimozide Pimozide | 1件: D00560
D00560
| 2件: ADRA2A ADRA2A, DRD2 💬 | 9件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
406 | Pimozide 2 mg per day | 1件: Pimozide Pimozide | 1件: D00560
D00560
| 2件: ADRA2A ADRA2A, DRD2 💬 | 9件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
407 | Pimozide 2mg/day (current) or 4 mg/day (study initiation) | 1件: Pimozide Pimozide | 1件: D00560
D00560
| 2件: ADRA2A ADRA2A, DRD2 💬 | 9件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
408 | Pimozide 4 mg per day | 1件: Pimozide Pimozide | 1件: D00560
D00560
| 2件: ADRA2A ADRA2A, DRD2 💬 | 9件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
409 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
410 | Pioglitazone and Tretinoin | 2件: Pioglitazone Pioglitazone, Tretinoin | 3件: D00094
D00094
,
D00945
,
D08378
| 4件: PML PML, PPARG, RARA, RARB 💬 | 21件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 2 2 |
411 | Plasma from healthy young people treatment + Riluzole | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
412 | PLECONARIL | 1件: Pleconaril Pleconaril | 1件: D05528
D05528
| - | - | 1件: 2 2 |
413 | PLENUR | - | - | - | - | 1件: 2 2 |
414 | PolyMVA | - | - | - | - | 1件: 2 2 |
415 | PowerLung trainer | - | - | - | - | 1件: 2 2 |
416 | Pramipexole | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 20 |
417 | Prednisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
418 | Pridopidine | 1件: Pridopidine Pridopidine | 1件: D09953
D09953
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 8 |
419 | Probiotic | - | - | - | - | 7件: 2 2, 6, 93, 96, 97, 193, 266 |
420 | Proleukin | 1件: Aldesleukin Aldesleukin | 1件: D00748
D00748
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 3件: 2 2, 49, 65 |
421 | Proleukin 18 MUI | 1件: Aldesleukin Aldesleukin | 1件: D00748
D00748
| 3件: IL2RA IL2RA, IL2RB, IL2RG 💬 | 14件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 2 2 |
422 | Prototype capsule GDC-0134 | - | - | - | - | 1件: 2 2 |
423 | PU-AD | - | - | - | - | 1件: 2 2 |
424 | Pulmonary Function Testing | - | - | - | - | 3件: 2 2, 228, 299 |
425 | PYRIMETHAMINE | 1件: Pyrimethamine Pyrimethamine | 1件: D00488
D00488
| - | - | 4件: 2 2, 4, 19, 65 |
426 | Q-Cells | - | - | - | - | 1件: 2 2 |
427 | Quinidine | 1件: Quinidine Quinidine | 4件: D00642
D00642
,
D00643
,
D02272
,
D08458
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 3件: 2 2, 8, 13 |
428 | R(+) pramipexole dihydrochloride monohydrate | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
429 | RA15804589, C19061501-F, DNL788, DN2489, DN0002489 | - | - | - | - | 1件: 2 2 |
430 | Rabeprazole | 1件: Rabeprazole Rabeprazole | 2件: D00724
D00724
,
D08463
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 2件: 2 2, 51 |
431 | Radiation: Modified Barium Swallow Study (MBSS) | 1件: Barium Barium | - | - | - | 1件: 2 2 |
432 | Ranolazine | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 6件: 2 2, 58, 86, 96, 113, 114 |
433 | Ranolazine 1000 MG | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 2 2 |
434 | Ranolazine 500 MG | 1件: Ranolazine Ranolazine | 2件: D05700
D05700
,
D05701
| - | - | 1件: 2 2 |
435 | RAPA-501 Autologous T cells | - | - | - | - | 1件: 2 2 |
436 | Rapamune | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 8件: 2 2, 60, 66, 67, 84, 158, 278, 280 |
437 | RAPAMUNE - 1 MG 100 COMPRESSE RIVESTITE IN BLISTER USO ORALE | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 1件: 2 2 |
438 | Rapamycin | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 19件: 2 2, 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 193, 256, 278, 279 |
439 | Rasagiline | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
440 | RASAGILINE MESILATE | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 3件: 2 2, 5, 6 |
441 | RAVULIZUMAB | 1件: Ravulizumab Ravulizumab | 1件: D11054
D11054
| 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 7件: 2 2, 11, 13, 50, 62, 66, 109 |
442 | Recombinant human erythropoietin(rhEPO) | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 2 2 |
443 | Reference capsule GDC-0134 | - | - | - | - | 1件: 2 2 |
444 | RELDESEMTIV | 1件: Reldesemtiv Reldesemtiv | 1件: D11363
D11363
| 1件: TNNC2 TNNC2 💬 | 1件: Calcium signaling pathway Calcium signaling pathway 💬 | 2件: 2 2, 3 |
445 | Repository corticotropin injection | 1件: Corticotropin Corticotropin | 1件: D00146
D00146
| 1件: MC2R MC2R 💬 | 5件: Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 5件: 2 2, 13, 46, 84, 222 |
446 | ReQuip CR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 2 2, 6 |
447 | Requip CR tablets | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 2 2 |
448 | Resveratrol | 1件: Resveratrol Resveratrol | - | - | - | 6件: 2 2, 8, 18, 89, 113, 299 |
449 | RETIGABINE | 1件: Ezogabine Ezogabine | 1件: D09569
D09569
| 5件: KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | 6件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | 2件: 2 2, 144 |
450 | RIBAVIRIN | 1件: Ribavirin Ribavirin | 1件: D00423
D00423
| - | - | 2件: 2 2, 96 |
451 | RILUTEK | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 13, 203 |
452 | Rilutek 50 mg film-coated tablets | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
453 | RILUTEK 50 mg, film-coated tablets | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
454 | RILUZOLE | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
455 | Riluzole (100 mg) | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
456 | Riluzole 50 MG | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
457 | Riluzole 50 MG (Part B) | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
458 | Riluzole Oral Soluble Film | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
459 | Riluzole Oral Soluble film (ROSF) 50 mg | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
460 | Riluzole tablet | 1件: Riluzole Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 2 2 |
461 | RILUZOLO | - | - | - | - | 3件: 2 2, 18, 114 |
462 | Ritonavir | 1件: Ritonavir Ritonavir | 1件: D00427
D00427
| - | - | 3件: 2 2, 86, 265 |
463 | RNS60 | - | - | - | - | 2件: 2 2, 13 |
464 | RT001 | - | - | - | - | 3件: 2 2, 5, 120 |
465 | RYAH-Medtech Inhaler | - | - | - | - | 5件: 2 2, 6, 13, 96, 97 |
466 | Saline solution | - | - | - | - | 4件: 2 2, 34, 288, 299 |
467 | SAR443820 | - | - | - | - | 1件: 2 2 |
468 | Sativex | 1件: Dronabinol Dronabinol | 1件: D00306
D00306
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 2 2, 13 |
469 | SB-509 | - | - | - | - | 1件: 2 2 |
470 | Scopolamine | 1件: Scopolamine Scopolamine | 1件: D00138
D00138
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 2 2 |
471 | Scopolamine, atropine, edaravone and dexmedetomidine | 4件: Atropine Atropine, Dexmedetomidine, Edaravone, Scopolamine | 9件: D00113
D00113
,
D00138
,
D00514
,
D01077
,
D01205
,
D01552
,
D02069
,
D03011
,
D03814
| 8件: ADRA2A ADRA2A, ADRA2B, ADRA2C, CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 14件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |
472 | Selective Serotonin Uptake Inhibitors (SSRI) | 1件: Serotonin Serotonin | - | - | - | 1件: 2 2 |
473 | Serine | 1件: Serine Serine | 1件: D00016
D00016
| - | - | 4件: 2 2, 6, 86, 96 |
474 | Serotonin | 1件: Serotonin Serotonin | - | - | - | 1件: 2 2 |
475 | Single dose reduced | - | - | - | - | 1件: 2 2 |
476 | Single dose standard | - | - | - | - | 1件: 2 2 |
477 | SLS | - | - | - | - | 1件: 2 2 |
478 | SLS-005 | - | - | - | - | 1件: 2 2 |
479 | SLS-005 Trehalose | 1件: Trehalose Trehalose | - | - | - | 1件: 2 2 |
480 | SNN0029 | - | - | - | - | 1件: 2 2 |
481 | SNN0029 infusion solution | - | - | - | - | 1件: 2 2 |
482 | Sodio phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 1件: 2 2 |
483 | Sodium phenylbutyrate | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 4件: 2 2, 3, 8, 251 |
484 | SODIUM PYRUVATE | - | - | - | - | 2件: 2 2, 67 |
485 | Sodium Valproate | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 4件: 2 2, 90, 102, 256 |
486 | Somatropin | 1件: Somatotropin Somatotropin | 1件: D02691
D02691
| 1件: GHR GHR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬 | 19件: 2 2, 3, 19, 46, 65, 74, 75, 78, 96, 107, 113, 187, 193, 195, 238, 265, 274, 276, 299 |
487 | SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 2 2 |
488 | Spirit1 | - | - | - | - | 1件: 2 2 |
489 | Stem Cell | - | - | - | - | 2件: 2 2, 113 |
490 | Stem cell (HPC) implantation | - | - | - | - | 1件: 2 2 |
491 | Stem Cells | - | - | - | - | 4件: 2 2, 4, 96, 113 |
492 | Stereotactic surgical device | - | - | - | - | 1件: 2 2 |
493 | SUB126308 | - | - | - | - | 1件: 2 2 |
494 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
495 | Suspension of human autologous MSC 3P in 1,5 ml | - | - | - | - | 1件: 2 2 |
496 | Suspension of human autologous MSC 3P in 1.5 ml | - | - | - | - | 1件: 2 2 |
497 | Synthetic stereopure antisense oligonucleotide targeting human C9orf72 hexanucleotide repeat-containing mRNA transcripts | - | - | - | - | 2件: 2 2, 127 |
498 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
499 | Talampanel | 1件: Talampanel Talampanel | 1件: D02696
D02696
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 6 |
500 | Tallampanel | - | - | - | - | 1件: 2 2 |
501 | Tamoxifen | 1件: Tamoxifen Tamoxifen | 2件: D00966
D00966
,
D08559
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 4件: 2 2, 86, 113, 227 |
502 | Tamoxifen 40 mg daily for one year | 1件: Tamoxifen Tamoxifen | 2件: D00966
D00966
,
D08559
| 2件: ESR1 ESR1, ESR2 💬 | 10件: Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬 | 1件: 2 2 |
503 | Taurolite | - | - | - | - | 1件: 2 2 |
504 | TAUROURSODEOXYCHOLIC ACID | 1件: Tauroursodeoxycholic acid Tauroursodeoxycholic acid | 1件: D11836
D11836
| - | - | 4件: 2 2, 13, 93, 299 |
505 | Tauroursodeoxycholic acid (TUDCA) | 1件: Tauroursodeoxycholic acid Tauroursodeoxycholic acid | 1件: D11836
D11836
| - | - | 1件: 2 2 |
506 | Taurursodiol | - | - | - | - | 1件: 2 2 |
507 | TCH346 | - | - | - | - | 1件: 2 2 |
508 | Tenofovir | 1件: Tenofovir disoproxil Tenofovir disoproxil | 1件: D01982
D01982
| - | - | 6件: 2 2, 13, 25, 93, 265, 325 |
509 | Tenofovir alafenamide | 2件: Tenofovir Tenofovir, Tenofovir alafenamide | 2件: D06074
D06074
,
D10428
| - | - | 2件: 2 2, 13 |
510 | Tenofovir alafenamide (TAF) | 2件: Tenofovir Tenofovir, Tenofovir alafenamide | 2件: D06074
D06074
,
D10428
| - | - | 1件: 2 2 |
511 | Testosterone | 1件: Testosterone Testosterone | 6件: D00075
D00075
,
D00957
,
D00958
,
D00959
,
D06085
,
D06087
| 1件: AR AR 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬 | 9件: 1 1, 2, 3, 13, 60, 76, 78, 113, 265 |
512 | TEVAGRASTIM | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 2 2 |
513 | Thalidomide | 1件: Thalidomide Thalidomide | 1件: D00754
D00754
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
514 | Thalidomide (drug) | 1件: Thalidomide Thalidomide | 1件: D00754
D00754
| 1件: TNF TNF 💬 | 67件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | 1件: 2 2 |
515 | Theracurmin HP | - | - | - | - | 1件: 2 2 |
516 | Tioctic acid | - | - | - | - | 1件: 2 2 |
517 | Tirasemtiv | 1件: Tirasemtiv Tirasemtiv | 1件: D10327
D10327
| - | - | 1件: 2 2 |
518 | TJ-68 | - | - | - | - | 1件: 2 2 |
519 | Tocilizumab | 1件: Tocilizumab Tocilizumab | 1件: D02596
D02596
| 1件: IL6R IL6R 💬 | 12件: Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 21件: 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331 |
520 | Tocotrienols | - | - | - | - | 1件: 2 2 |
521 | Tofersen | 1件: Tofersen Tofersen | 1件: D11811
D11811
| 1件: SOD1 SOD1 💬 | 8件: Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Chemical carcinogenesis - reactive oxygen species, Huntington disease, Longevity regulating pathway - multiple species, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Peroxisome, Prion disease 💬 | 1件: 2 2 |
522 | TPN-101 | - | - | - | - | 2件: 2 2, 127 |
523 | TPN-101, 400 mg/day | - | - | - | - | 3件: 2 2, 5, 127 |
524 | Trametinib | 1件: Trametinib Trametinib | 1件: D10175
D10175
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 3件: 2 2, 34, 279 |
525 | Trametinib (0.5 mg) | 1件: Trametinib Trametinib | 1件: D10175
D10175
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 2 2 |
526 | Trametinib (1 mg) | 1件: Trametinib Trametinib | 1件: D10175
D10175
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 2 2 |
527 | Trametinib (2 mg) | 1件: Trametinib Trametinib | 1件: D10175
D10175
| 2件: MAP2K1 MAP2K1, MAP2K2 💬 | 89件: Acute myeloid leukemia Acute myeloid leukemia, Alcoholism, Alzheimer disease, Apelin signaling pathway, Apoptosis, Autophagy - animal, B cell receptor signaling pathway, Bladder cancer, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Influenza A, Insulin signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-small cell lung cancer, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Serotonergic synapse, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid cancer, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, VEGF signaling pathway, Vascular smooth muscle contraction, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway, mTOR signaling pathway 💬 | 1件: 2 2 |
528 | Trazodone | 1件: Trazodone Trazodone | 2件: D00820
D00820
,
D08626
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 2 2 |
529 | Trazodone Hydrochloride oral solution | 1件: Trazodone Trazodone | 2件: D00820
D00820
,
D08626
| 4件: HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 2 2 |
530 | Trehalose | 1件: Trehalose Trehalose | - | - | - | 2件: 2 2, 113 |
531 | Tretinoin | 1件: Tretinoin Tretinoin | 1件: D00094
D00094
| 3件: PML PML, RARA, RARB 💬 | 12件: Acute myeloid leukemia Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Influenza A, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 3件: 2 2, 62, 75 |
532 | Tretinoin and Pioglitazone HCL | 2件: Pioglitazone Pioglitazone, Tretinoin | 3件: D00094
D00094
,
D00945
,
D08378
| 4件: PML PML, PPARG, RARA, RARB 💬 | 21件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Endocytosis, Estrogen signaling pathway, Gastric cancer, Herpes simplex virus 1 infection, Huntington disease, Influenza A, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Ubiquitin mediated proteolysis 💬 | 1件: 2 2 |
533 | Tricyclic Antidepressants (TCA) | - | - | - | - | 1件: 2 2 |
534 | Triheptanoin | 1件: Triheptanoin Triheptanoin | 1件: D11465
D11465
| - | - | 10件: 2 2, 8, 65, 149, 156, 248, 256, 257, 317, 324 |
535 | Trimetazidine | 1件: Trimetazidine Trimetazidine | 1件: D08642
D08642
| - | - | 3件: 2 2, 58, 86 |
536 | Trimetazidine Dihydrochloride | 1件: Trimetazidine Trimetazidine | 1件: D08642
D08642
| - | - | 2件: 2 2, 58 |
537 | Triumeq | 1件: Dolutegravir Dolutegravir | 1件: D10066
D10066
| - | - | 1件: 2 2 |
538 | TRO19622 | 1件: TRO19622 TRO19622 | - | - | - | 3件: 2 2, 3, 13 |
539 | Trobalt | 1件: Ezogabine Ezogabine | 1件: D09569
D09569
| 5件: KCNQ1 KCNQ1, KCNQ2, KCNQ3, KCNQ4, KCNQ5 💬 | 6件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection 💬 | 1件: 2 2 |
540 | TUDCA | 1件: Tauroursodeoxycholic acid Tauroursodeoxycholic acid | 1件: D11836
D11836
| - | - | 1件: 2 2 |
541 | TUDCABIL | - | - | - | - | 1件: 2 2 |
542 | TV-7110 | - | - | - | - | 1件: 2 2 |
543 | Téralithe LP | - | - | - | - | 1件: 2 2 |
544 | Ultomiris | 1件: Ravulizumab Ravulizumab | 1件: D11054
D11054
| 1件: C5 C5 💬 | 10件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 6件: 2 2, 11, 13, 50, 62, 66 |
545 | Ultra-high-caloric carbohydrate-rich diet | - | - | - | - | 1件: 2 2 |
546 | Ultra-high-caloric fatty diet | - | - | - | - | 1件: 2 2 |
547 | Umbilical cord blood therapy | 1件: Umbilical Cord Blood Hematopoietic Stem Cells Umbilical Cord Blood Hematopoietic Stem Cells | - | - | - | 2件: 2 2, 6 |
548 | Ursodoxicoltaurina | - | - | - | - | 1件: 2 2 |
549 | Ursodoxicoltaurine | - | - | - | - | 1件: 2 2 |
550 | Valproate | 1件: Valproic acid Valproic acid | 1件: D00399
D00399
| 7件: ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 | 17件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | 6件: 2 2, 3, 90, 102, 233, 256 |
551 | Vastarel | - | - | - | - | 2件: 2 2, 58 |
552 | Verdiperstat | 1件: Verdiperstat Verdiperstat | 1件: D11684
D11684
| 1件: MPO MPO 💬 | 5件: Acute myeloid leukemia Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer 💬 | 3件: 2 2, 17, 127 |
553 | Videofluoroscopic Swallowing Study | - | - | - | - | 1件: 2 2 |
554 | Videofluoroscopic Swallowing Study (VFSS) | - | - | - | - | 1件: 2 2 |
555 | Vitamin E | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 11件: 2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 |
556 | VM202 | - | - | - | - | 1件: 2 2 |
557 | Voluntary Peak Cough Flow Testing | - | - | - | - | 1件: 2 2 |
558 | Water | 1件: Water Water | 1件: D00001
D00001
| - | - | 23件: 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
559 | WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS | - | - | - | - | 1件: 2 2 |
560 | Withania somnifera | - | - | - | - | 1件: 2 2 |
561 | WVE-004 | - | - | - | - | 2件: 2 2, 127 |
562 | YAM80 | - | - | - | - | 1件: 2 2 |
563 | Zibren | - | - | - | - | 1件: 2 2 |
564 | ZIBREN*20BUST 500MG | - | - | - | - | 1件: 2 2 |
565 | Zilucoplan | 1件: Zilucoplan Zilucoplan | - | - | - | 3件: 2 2, 11, 62 |
566 | Zinc | 1件: Zinc Zinc | - | - | - | 3件: 2 2, 171, 299 |
567 | Zinc and Copper | 2件: Copper Copper, Zinc | - | - | - | 1件: 2 2 |
568 | Zyprexa | 1件: Olanzapine Olanzapine | 2件: D00454
D00454
,
D06623
| 11件: ADRA1A ADRA1A, ADRA1B, ADRA1D, DRD2, DRD3, DRD4, HRH1, HTR2A, HTR2B, HTR2C, HTR6 💬 | 16件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Salivary secretion, Serotonergic synapse, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 2 2 |